Influence of blockers for the estrogen receptor (ER) and type 1 IGF-receptor on the levels of ER, ER mRNA and IGF-I mRNA in the rat uterus

Journal of Steroid Biochemistry and Molecular Biology

Volumn 58, Issue 4, 1996, Pages 359-365

  Sahlin, Lena ^a   Eriksson, Håkan ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; FULVESTRANT; MESSENGER RNA; SOMATOMEDIN C DERIVATIVE; SOMATOMEDIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; NONHUMAN; OVARIECTOMY; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; UTERUS; UTERUS GROWTH;

ANIMALIA;

EID: 0030199834     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-0760(96)00053-2     Document Type: Article

References (28)

1. 1. McCormack S. A. and Glasser S. R.: Differential response of individual uterine cell types from immature rats treated with estradiol. Endocrinology 106 (1980) 1634-1649.
2. 2. Toomoka Y., DiAugustine R. P. and McLachlan J. A.: Proliferation of mouse uterine epithelial cells in vitro. Endocrinology 118 (1986) 1011-1018.
3. 3. Astrahantseff K. N. and Morris J. E.: Estradiol-17β stimulates proliferation of uterine epithelial cells cultured with stromal cells but not cultured separately. In Vitro Cell. Dev. Biol. 30A (1994) 769-776.
4. 4. Sirbasku D. A. and Benson R. H.: Estrogen-inducible growth factors that may act as mediators (estromedins) of estrogen-promoted tumor cell growth. In Hormones and cell culture (Edited by G. S. Sato and R. Ross). Cold Spring Harbor, NY (1979) 477-490.
5. 5. Murphy L. J., Murphy L. C. and Friesen H. G.: Estrogen induces insulin-like growth factor-I expression in the rat uterus. Molec. Endocr. 1 (1987) 445-450.
6. 6. Norstedt G., Levinovitz A. and Eriksson H.: Regulation of uterine insulin-like growth factor I mRNA and insulin-like growth factor II mRNA by estrogen in the rat. Acta Endocrinol. (Copenhagen) 120 (1989) 466-472.
7. 7. Ghahary A., Chakrabarti S. and Murphy L. J.: Localization of the sites of synthesis and action of insulin-like growth factor-I in the rat uterus. Molec. Endocr. 4 (1990) 191-195.
8. 8. Aronica S. M. and Katzenellenbogen B. S.: Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I. Molec. Endocr. 7 (1993) 743-752.
9. 9. Sahlin L., Norstedt G. and Eriksson H.: Estrogen regulation of the estrogen receptor and insulin-like growth factor-I in the rat uterus: a potential coupling between effects of estrogen and IGF-I. Steroids 59 (1994) 421-430.
10. 10. Murphy L. C.: Antiestrogen action and growth factor regulation. Breast Cancer Res. Treatm. 31 (1994) 61-71.
11. 11. Huynh H. and Pollak M.: Insulin-like growth factor I gene expression in the uterus is stimulated by tamoxifen and inhibited by the pure antiestrogen ICI 182780. Cancer Res. 53 (1993) 5585-5588.
12. 12. Eriksson H.: Estrogen binding sites of mammalian liver: endocrine regulation of estrogen receptor synthesis in the regenerating rat liver. J. Steroid Biochem. 17 (1982) 471-477.
13. 13. Eriksson H.: Different regulation of the concentration of estrogen receptors in the rat liver and uterus following ovariectomy. FEBS Lett. 149 (1982) 91-95.
14. 14. Wakeling A. E., Dukes M. and Bowler J.: A potent specific pure antiestrogen with clinical potential. Cancer Res. 51 (1991) 3867-3873.
15. 15. Pietrzkowski Z., Wernicke D., Porcu P., Jameson B. A. and Baserga R.: Inhibition of cellular proliferation by peptide analogues of insulin-like growth factor I. Cancer Res. 52 (1992) 6447-6451.
16. 16. Korenman S. G., Perrin L. E. and McCallum T. P.: A radio-ligand binding assay system for estradiol measurement in human plasma. J. Clin. Endocr. Metab. 29 (1969) 879-883.
17. 17. Clark J. H. and Peck Jr. E. J.: Female Sex Steroids. Receptors and Function. Springer Verlag, Berlin (1979).
18. 18. Scatchard G.: The attractions of proteins for small molecules and ions. Ann. N.Y. Acad. Sci. 51 (1949) 660-672.
19. 19. Lowry O. H., Rosebrough N. J., Farr A. L. and Randall R. J.: Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275.
20. 20. Scheffé H. The analysis of variance. John Wiley, New York (1959).
21. 21. Mathews L. S., Norstedt G. and Palmiter R. D.: Regulation of insulin-like growth factor I gene expression by growth hormone. Proc. Natn. Acad. Sci. U.S.A. 83 (1986) 9343-9347.
22. 22. Hillier S. G., Saunders P. T. K., White R. and Parker M. G.: Estrogen receptor mRNA and a related RNA transcript in mouse ovaries. J. Molec. Endocr. 2 (1989) 39-45.
23. 23. Möller C., Arner P., Sonnenfeld T. and Norstedt G.: Quantitative comparison of insulin-like growth factor mRNA levels in human and rat tissues analysed by a solution hybridization assay. J. Molec. Endocr. 7 (1991) 213-222.
24. 24. Wakeling A. E. and Bowler J.: ICI 182,780, a new antiestrogen with clinical potential. J. Steroid Biochem. Molec. Biol. 43 (1992) 173-177.
25. 25. Molnar P. and Murphy L. J.: Effects of estrogen on rat uterine expression of insulin-like growth factor-binding proteins. J. Molec. Endocr. 13 (1994) 59-67.
26. 26. Huynh H. and Pollak M.: Uterotrophic actions of estradiol and tamoxifen are associated with inhibition of uterine insulin-like growth factor binding protein 3 gene expression. Cancer Res. 54 (1994) 3115-3119.
27. 27. Nelson K. G., Takahashi T., Bossert N. L., Walmer D. K. and McLachlan J. A.: Epidermal growth factor replaces estrogen in the stimulation on female genital-tract growth and differentiation. Proc. Natn. Acad. Sci. U.S.A. 88 (1991) 21-25.
28. 28. Nelson K. G., Takahashi T., Lee D. C., Luetteke N. C., Bossert N. L., Ross K., Eitzman B. E. and McLachlan J. A.: Transforming growth factor - is a potential mediator of estrogen action in the mouse uterus. Endocrinology 131 (1992) 1657-1664.